Search Login Register

Tegafur Summary

Description: Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms.

Also Known As: 1-(2-Tetrahydrofuryl)-5-fluorouracil; 1-(Tetrahydro-2-furanyl)-5-fluorouracil; 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione; Almirall Brand of Tegafur; Bristol-Myers Squibb Brand of Tegafur Show All >>

Networked: 1260 relevant articles (149 outcomes, 378 trials/studies) for this Bio-Agent

Key Diseases for which Tegafur is Relevant

  1. Colorectal Neoplasms (Colorectal Cancer) : 28 outcomes 76 studies in 184 results
  2. Neoplasms (Cancer) : 27 outcomes 41 studies in 338 results
  3. Stomach Neoplasms (Stomach Cancer) : 20 outcomes 66 studies in 197 results
  4. Neoplasm Metastasis (Metastasis) : 15 outcomes 12 studies in 107 results
  5. Breast Neoplasms (Breast Cancer) : 13 outcomes 46 studies in 98 results
Show All >>

Drugs Related to Tegafur

  1. Uracil
  2. Leucovorin (Folinic Acid)
  3. Fluorouracil (Carac)
  4. Mitomycin (Mitomycin-C)
  5. Cisplatin (Platino)
  6. Tegafur
  7. Cyclophosphamide (Cytoxan)
  8. Doxorubicin (Adriamycin)
  9. irinotecan (Camptosar)
  10. krestin (PSK)
Show All >>

Therapies Related to Tegafur

  1. Drug Therapy (Chemotherapy)
  2. Adjuvant Chemotherapy
  3. Oral Administration
  4. Combination Drug Therapy (Combination Chemotherapy)
  5. Intravenous Injections
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.